Anatara Lifesciences Financials

ANR Stock   0.06  0  1.72%   
We suggest to use Anatara Lifesciences fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Anatara Lifesciences is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate data for twenty-five available fundamental indicators for Anatara Lifesciences, which can be compared to its peers. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Anatara Lifesciences to be traded at 0.0553 in 90 days. Key indicators impacting Anatara Lifesciences' financial strength include:
Operating Margin
2.846
Return On Equity
(1.27)
  
Understanding current and past Anatara Lifesciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Anatara Lifesciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Anatara Lifesciences' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Anatara Lifesciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Anatara Lifesciences. Check Anatara Lifesciences' Beneish M Score to see the likelihood of Anatara Lifesciences' management manipulating its earnings.

Anatara Lifesciences Stock Summary

Anatara Lifesciences competes with Aurelia Metals, Pinnacle Investment, Data3, Auctus Alternative, and Dicker Data. Anatara Lifesciences is entity of Australia. It is traded as Stock on AU exchange.
Foreign Associate
  USA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentAustralia Stock View All
ExchangeAustralian Securities Exchange
ISINAU000000ANR0
Business Address81 Flinders Street,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websiteanataralifesciences.com
Phone61 4 3802 7172
You should never invest in Anatara Lifesciences without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Anatara Stock, because this is throwing your money away. Analyzing the key information contained in Anatara Lifesciences' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Anatara Lifesciences Key Financial Ratios

Anatara Lifesciences' financial ratios allow both analysts and investors to convert raw data from Anatara Lifesciences' financial statements into concise, actionable information that can be used to evaluate the performance of Anatara Lifesciences over time and compare it to other companies across industries.

Anatara Lifesciences Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets3.3M4.3M1.8M1.4M1.7M1.6M
Cash2.7M3.4M1.1M351.2K982.1K933.0K
Net Receivables630.3K772.6K508.5K1.0M671.1K518.6K
Total Liab487.0K496.7K403.4K494.8K306.8K433.2K
Common Stock17.0M19.8M19.9M21.4M23.2M14.6M
Other Current Assets23.7K37.1K22.0K10.9K17.4K16.6K
Other Current Liab430.2K192.9K184.8K415.3K56.1K53.3K
Net Debt(2.7M)(3.4M)(1.1M)(351.2K)(982.1K)(1.0M)
Retained Earnings(14.7M)(16.6M)(19.0M)(20.8M)(22.1M)(21.0M)
Accounts Payable33.9K195.6K152.6K78.8K248.0K149.2K
Total Current Assets3.3M4.2M1.7M1.4M1.7M1.6M
Net Tangible Assets2.9M3.8M1.4M924.5K832.1K790.5K
Net Invested Capital2.9M3.8M1.4M924.5K1.4M1.3M
Net Working Capital2.9M3.8M1.3M921.9K1.4M1.3M
Other Liab22.9K28.3K81.0665.0598.5568.57
Capital Stock17.0M19.8M19.9M21.4M23.2M21.7M

Anatara Lifesciences Key Income Statement Accounts

201920202021202220232024 (projected)
Research Development1.3M840.8K747.2K1.6M748.9K781.0K
Cost Of Revenue16.1K6.3K24.7K24.8K748.9K786.4K
Gross Profit(16.1K)(6.3K)(24.7K)(24.8K)(748.9K)(711.5K)
Operating Income(4.2M)(3.1M)(3.0M)(3.3M)(1.5M)(1.5M)
Ebit(4.0M)(3.0M)(3.0M)(3.2M)(1.5M)(1.5M)
Ebitda(4.0M)(3.0M)(3.0M)(3.2M)(1.5M)(1.5M)
Income Before Tax(4.0M)(3.0M)(3.0M)(3.2M)(2.1M)(2.2M)
Net Income(3.4M)(2.0M)(2.5M)(2.0M)(1.5M)(1.5M)
Income Tax Expense(659.8K)(1.0M)(468.5K)(1.2M)(626.1K)(657.4K)
Net Interest Income52.1K8.8K2.7K15.9K7.9K7.5K
Interest Income52.1K9.1K6.0K18.3K7.9K7.5K

Anatara Lifesciences Key Cash Accounts

201920202021202220232024 (projected)
End Period Cash Flow2.7M3.4M1.1M351.2K982.1K1.8M
Change In Cash1.3M749.7K(2.3M)(769.0K)630.9K662.5K
Free Cash Flow(2.7M)(2.1M)(2.2M)(2.3M)(1.2M)(1.3M)
Other Non Cash Items72.0K272.7K(106.4K)442.9K(170.4K)(161.9K)
Net Income(3.4M)(2.0M)(2.5M)(2.0M)(1.5M)(1.5M)
Investments4.1M(4.0K)(50K)(1.7K)50K52.5K
Depreciation16.1K6.3K24.7K24.8K2.5K2.3K
Change To Netincome305.5K117.9K74.8K70.9K63.8K60.6K
Change To Inventory(931.9K)732.8K64.1K(165.2K)(190.0K)(180.5K)

Anatara Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Anatara Lifesciences's current stock value. Our valuation model uses many indicators to compare Anatara Lifesciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Anatara Lifesciences competition to find correlations between indicators driving Anatara Lifesciences's intrinsic value. More Info.
Anatara Lifesciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Anatara Lifesciences' earnings, one of the primary drivers of an investment's value.

Anatara Lifesciences Systematic Risk

Anatara Lifesciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Anatara Lifesciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Anatara Lifesciences correlated with the market. If Beta is less than 0 Anatara Lifesciences generally moves in the opposite direction as compared to the market. If Anatara Lifesciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Anatara Lifesciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Anatara Lifesciences is generally in the same direction as the market. If Beta > 1 Anatara Lifesciences moves generally in the same direction as, but more than the movement of the benchmark.

Anatara Lifesciences Total Assets Over Time

Anatara Lifesciences November 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Anatara Lifesciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Anatara Lifesciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Anatara Lifesciences based on widely used predictive technical indicators. In general, we focus on analyzing Anatara Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Anatara Lifesciences's daily price indicators and compare them against related drivers.

Additional Tools for Anatara Stock Analysis

When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.